ScholarIQanswers from OpenAlex

Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma

PaperCitations, authors & open-access status

Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma have?

ScholarIQcitation count

Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma has 41 citations in the OpenAlex counts ScholarIQ stores.

When was Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma published?

ScholarIQyear

Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma has 2018 year in the ScholarIQ index.

What is the open-access status of Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma?

ScholarIQoa status

Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma has closed oa status in the ScholarIQ index.

What is the DOI of Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma?

ScholarIQdoi

The DOI for Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma is on the source record.

What is the PMID of Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma?

ScholarIQpmid

The PMID for Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma is on the source record.

What is the OpenAlex record for Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma?

ScholarIQopenalex

The OpenAlex for Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial